{"entity":{"type":"insider","cik":"0001778075","url":"/insider/0001778075","json_url":"/insider/0001778075.json","name":"Ginascol John F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2020-03-03","last":"2023-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Ginascol John F","source":"filing","n_filings":6,"first_seen":"2020-03-03","last_seen":"2023-03-02"}],"transactions":[{"id":8028501,"accession":"0001415889-23-003908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-003908","line_url":"/filing/0001415889-23-003908#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001778075","owner_name":"Ginascol John F","owner_display_name":"Ginascol John F","owner_url":"/insider/0001778075","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":943.0,"shares_display":"943","price_per_share":100.7,"price_display":"100.70","price_state":"stated","total_value":94960.1,"total_display":"94,960.10","total_whole":"94,960","shares_owned_after":118380.0,"shares_owned_after_display":"118,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":6315864,"accession":"0001415889-22-012600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-012600","line_url":"/filing/0001415889-22-012600#line-1","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001778075","owner_name":"Ginascol John F","owner_display_name":"Ginascol John F","owner_url":"/insider/0001778075","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":112.32,"price_display":"112.32","price_state":"stated","total_value":1235520.0,"total_display":"1,235,520.00","total_whole":"1,235,520","shares_owned_after":111912.0,"shares_owned_after_display":"111,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-15","scope":"insider"},{"id":6679923,"accession":"0001415889-22-002193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002193","line_url":"/filing/0001415889-22-002193#line-1","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001778075","owner_name":"Ginascol John F","owner_display_name":"Ginascol John F","owner_url":"/insider/0001778075","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":365.0,"shares_display":"365","price_per_share":118.1602,"price_display":"118.16","price_state":"stated","total_value":43128.473,"total_display":"43,128.47","total_whole":"43,128","shares_owned_after":124680.0,"shares_owned_after_display":"124,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":5388199,"accession":"0001415889-21-001206","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-21-001206","line_url":"/filing/0001415889-21-001206#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001778075","owner_name":"Ginascol John F","owner_display_name":"Ginascol John F","owner_url":"/insider/0001778075","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":352.0,"shares_display":"352","price_per_share":120.61,"price_display":"120.61","price_state":"stated","total_value":42454.72,"total_display":"42,454.72","total_whole":"42,455","shares_owned_after":99321.0,"shares_owned_after_display":"99,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":2973371,"accession":"0001179110-20-005071","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-005071","line_url":"/filing/0001179110-20-005071","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001778075","owner_name":"Ginascol John F","owner_display_name":"Ginascol John F","owner_url":"/insider/0001778075","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63200.0,"shares_display":"63,200","price_per_share":95.99763549050633,"price_display":"96.00","price_state":"stated","total_value":6067050.563,"total_display":"6,067,050.56","total_whole":"6,067,051","shares_owned_after":66445.0,"shares_owned_after_display":"66,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-21","filed_date":"2020-04-23","scope":"insider","n_lines":2},{"id":2574782,"accession":"0001179110-20-002899","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-002899","line_url":"/filing/0001179110-20-002899","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001778075","owner_name":"Ginascol John F","owner_display_name":"Ginascol John F","owner_url":"/insider/0001778075","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6606.0,"shares_display":"6,606","price_per_share":77.62720859824402,"price_display":"77.63","price_state":"stated","total_value":512805.34,"total_display":"512,805.34","total_whole":"512,805","shares_owned_after":66445.0,"shares_owned_after_display":"66,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000001800","name":"ABBOTT LABORATORIES","url":"/issuer/0000001800","role":"Officer (EXECUTIVE VICE PRESIDENT)","n_filings":6,"first_seen":"2020-03-03","last_seen":"2023-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001778075","retrieved_at":"2026-08-22T16:39:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}